eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
1/2016
vol. 33
 
Share:
Share:
more
 
 
abstract:
Original paper

A study of the activity and effectiveness of recombinant fibroblast growth factor (Q40P/S47I/H93G rFGF-1) in anti-aging treatment

Justyna Żerańska, Monika Pasikowska, Barbara Szczepanik, Krzysztof Mlosek, Sylwia Malinowska, Renata M. Dębowska, Irena Eris

Adv Dermatol Allergol 2016; XXXIII (1): 28–36
Online publish date: 2016/02/29
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction: Fibroblast growth factor 1 (FGF-1) is a powerful mitogen involved in the stimulation of DNA synthesis and the proliferation of a wide variety of cell types. Fibroblast growth factor 1 was genetically modified to improve its thermal stability and resistance to protease degradation without losing its biological activity.

Aim: To study the impact of Q40P/S47I/H93G rFGF-1 on skin cells, its penetration through the skin and the evaluation of the rFGF-1-cosmetic product properties.

Material and methods: In vitro studies included the examination of primary fibroblast and keratinocyte viability after the incubation with rFGF-1. The penetration abilities of rFGF-1 in various formulations and carrier systems were examined ex vivo by the Raman spectroscopy. In vivo studies – HF Ultrasound and 3D Imaging System – were used to evaluate the anti-aging properties of creams containing rFGF-1.

Results: In vitro studies demonstrated that rFGF-1 strongly enhanced the viability of the treated cells. The Raman Spectroscopy analysis indicated that rFGF-1 encapsulated in lipid spheres penetrate through the stratum corneum to the depth of 60 μm, and added to the o/w formulation – could penetrate to a depth of 90 μm. The results obtained from Primos revealed the reduction of the volume and the depth of the wrinkles. Changes in the skin structure in the analyzed areas were evaluated by HF Ultrasonography.

Conclusions: Recombinant FGF-1 strongly stimulated fibroblast and keratinocyte proliferation. However, the transition of this protein through the SC required an appropriate carrier system – lipid spheres. All tests – in vitro, ex vivo and in vivo – have proved that rFGF-1 is a substance with a potentially wide spectrum of use.
keywords:

HF ultrasonography, Primos, keratinocytes, Raman spectroscopy

references:
Mehta RC, Fitzpatrick RE. Endogenous growth factors as cosmeceuticals. Dermatol Ther 2007; 20: 350-9.
Hilling C. Human growth factors as natural healers: current literature and application. Cosmetics and Toiletries 2010; 125: 73-7.
Zakrzewska M, Krowarsch D, Wiedlocha A, et al. Design of fully active FGF-1 variants with increased stability. Protein Eng Des Sel 2004; 17: 603-11.
Nedoszytko B, Sokołowska-Wojdyło M, Ruckemann-Dziurdzińska K, et al. Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis. Postep Derm Alergol 2014; 31: 84-91.
Zakrzewska M, Krowarsch D, Wiedlocha A, et al. Highly stable mutants of human fibroblast growth factor-1 exhibit enhanced biological activity. J Mol Biol 2005; 352: 860-75.
Szlachcic A, Zakrzewska M, Krowarsch D, et al. Structure of highly stable mutant of human fibroblast growth factor 1. Acta Cryst 2009; D65: 67-73.
Boukamp P, Petrussevska RT, Breitkreutz D, et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-71.
WIPO ST 10/C PL400804.
Mlosek R, Malinowska S, Dębowska R, et al. The use of high frequency ultrasound imaging in skin moisturization measurement. Skin Res Technol 2013; 19: 169-75.
Dzwigałowska A, Sołyga-Żurek A, Dębowska R, Eris I. Preliminary study in the evaluation of anti-aging cosmetic treatment using two complementary methods for assessing skin surface. Skin Res Technol 2013, 19: 155-61.
Zhang K, Tian Y, Yin L, et al. FGF-P improves barrier function and proliferation in human keratinocytes after radiation. Int J Radiat Oncol Biol Phys 2011; 81: 248-54.
Anitua E, Sanchez M, Merayo-Lloves J, et al. Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-induced myodifferentiation. Investig Ophthalmol Visual Sci 2011; 52: 6066-73.
Morrow DIJ, McCarron PA, Woolfson AD, Donnelly RF. Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv J 2007; 1: 36-59.
Orłowski P, Krzyżowska M, Winnicka A, et al. Toxicity of silver nanoparticles in monocytes and keratinocytes: potential to induce inflammatory reactions. Centr Eur J Immunol 2012; 37: 123-30.
Cal K. Across the skin barrier: known methods, new performances. In: Caldwell GW, ur-Rahman A, Yan Z, Choundhary MI. Frontiers in drug design and discovery. Bentham Science Publishers 2009; 4: 162-88.
Souto EB, Muller RH. Cosmetic features and applications of lipid nanoparticles (SLN, NLC). Int J Cosmet Sci 2008; 30: 157-65.
Zakrzewska M. Mutational analysis of human acidic fibroblast growth factor –FGF1. PhD Work, University of Wroclaw, Faculty of Natural Science 2005.
Caspers PJ, Lucassen GW, Puppels GJ. Combined in vivo confocal Raman spectroscopy and confocal microscopy of human skin. Biophys J 2003; 85: 572-80.
Pacholczyk B, Fabiańska A, Kusińska R. Analysis of cancer tissues by means of spectroscopic methods. Contemp Oncol 2012; 16: 290-4.
Muller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 2007; 59: 522-30.
Fitzpatric RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Lase Ther 2003; 5: 25-34.
Ehrlich M, Rao J, Pabby A, Goldman MP. Improvement in the appearance of wrinkles with topical transforming growth factor beta(1) and 1-ascorbic acid. Dermatol Surg 2006; 32: 618-25.
Gold MH, Goldmann MP, Biron J. Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation. J Drug Dermatol 2007; 6: 197-201.
Rhein RD. Aging skin – general considerations. In: Aging skin: current and therapeutic strategies. Rhein LD, Fluhr J (eds). Allured Business Media 2010.
FEATURED PRODUCTS
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe